SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transformational treatments for critically ill patients facing organ failure and potential loss of ...
Penumbra has announced results from a subset analysis of the landmark STORM-PE randomised controlled trial (RCT), the first ...
A two-year real-world study found that ofatumumab sustained B-cell depletion in multiple sclerosis patients while producing ...
Wearable-derived data provide new insights into how clinical outcomes for patients treated with CAVT and anticoagulation, and ...
Penumbra, Inc. announced results from a subset analysis of the landmark STORM-PE randomized controlled trial (RCT), the first trial to demonstrate a significant correlation between real-world, daily ...
Bottom-up company analysis from the inaugural Solar Manufacturing USA event reveals that real domestic module supply depends ...
The sudden proliferation of Flock cameras and abuses has led to a response from Florida lawmakers, but they have stopped ...
Stock fell 20% due to competitive pressures from Eli Lilly's Mounjaro/Zepbound, failed CagriSema trials, and revised growth ...
New research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Milan, ...
Cytokinetics Announces Start of ASPEN-HCM Real-World Study of MYQORZO in Symptomatic Obstructive HCM
Cytokinetics launched a study assessing the real-world safety and effectiveness of MYQORZO in patients with obstructive ...
Who, really, is the best player in baseball? Ask five sports media outlets and you may get five different answers. Rankings ...
The math is visible. TREMFYA's $5.16 billion in 2025 replaces only about half of Stelara's 2023 peak. J&J's $10 billion peak ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results